Sharon Li

HiFiBiO Therapeutics

Poster(s):

• Th193 - Application of HiFiBiO Drug Intelligence Science (DIS®) Translational Platform to Guide the Clinical Development of HFB200604, a Phase I BTLA Agonist Monoclonal Antibody
  Thursday, June 26, 2025

  7:30am - 7:45pm East Coast USA Time